A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin

Ruijie Zhang, Xiaozhi Yang, Dana M. Roque, Chenglong Li, Jiayuh Lin

2020 · doi:10.1101/2020.09.22.307645

preprint OA: closed CC-BY-4.0

📄 Open PDF View at publisher

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (40)

Latest research and treatment of advanced-stage epithelial ovarian cancer. via crossref
Ovarian cancer statistics, 2018. via crossref
The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded via crossref
doi:10.1097/igc.0000000000001118 via crossref
doi:10.1080/01635581.2018.1380203 via crossref
doi:10.1200/jco.2006.06.3743 via crossref
doi:10.1158/1078-0432.ccr-04-2682 via crossref
doi:10.1007/s10147-012-0461-1 via crossref
doi:10.1371/journal.pone.0050519 via crossref
doi:10.1016/j.ccell.2015.05.009 via crossref
doi:10.1038/srep09529 via crossref
doi:10.1158/1078-0432.ccr-16-1562 via crossref
doi:10.1593/neo.91196 via crossref
doi:10.1590/1414-431x20133003 via crossref
doi:10.1124/pr.58.3.10 via crossref
doi:10.1038/s41419-019-1407-6 via crossref
doi:10.1186/1476-4598-6-24 via crossref
doi:10.1158/0008-5472.can-19-0840 via crossref
doi:10.1038/nprot.2006.339 via crossref
doi:10.2147/cmar.s206175 via crossref
doi:10.1080/08977194.2018.1473393 via crossref
doi:10.1038/sj.onc.1204086 via crossref
doi:10.1158/1078-0432.ccr-06-0861 via crossref
doi:10.1158/0008-5472.can-03-3959 via crossref
doi:10.1002/cncr.22293 via crossref
doi:10.1038/onc.2011.409 via crossref
doi:10.1186/1741-7015-10-9 via crossref
doi:10.1016/j.biocel.2008.09.018 via crossref
doi:10.1006/gyno.2000.5931 via crossref
doi:10.1074/jbc.m107527200 via crossref
doi:10.1002/1097-0282(2001)60:1<32::aid-bip1002>3.0.co;2-i via crossref
doi:10.1038/sj.onc.1210031 via crossref
doi:10.1073/pnas.0609757104 via crossref
doi:10.1074/jbc.m114.616748 via crossref
doi:10.2174/1568009615666150916093110 via crossref
doi:10.1186/1746-6148-8-244 via crossref
doi:10.6004/jnccn.2013.0142 via crossref
doi:10.1007/s10637-011-9645-1 via crossref
doi:10.1007/s00404-017-4292-1 via crossref
doi:10.1007/s12032-017-0960-z via crossref

Source provenance

crossref: last seen: 2026-05-22T01:00:26.926819+00:00
europepmc: last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall: last seen: 2026-05-21T05:10:58.409756+00:00

License: CC-BY-4.0